Cancer TARGETases: DSB repair as a pharmacological target-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer TARGETases: DSB repair as a pharmacological target

Published:2016-05 Issue: Volume:161 Page:111-131
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Samadder Pounami,Aithal Rakesh,Belan Ondrej,Krejci Lumir

Funder

Czech Science Foundation

Research Support Programme (GAMU)

Ministry of Health of the Czech Republic

European Regional Development Fund

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference381 articles.

1. Cell cycle checkpoint signaling through the ATM and ATR kinases;Abraham;Genes Dev,2001

2. Hitting the bull's eye: Novel directed cancer therapy through helicase-targeted synthetic lethality;Aggarwal;J Cell Biochem,2009

3. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress;Aggarwal;Proc Natl Acad Sci U S A,2011

4. The Chk2 protein kinase;Ahn;DNA Repair,2004

5. Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy;Al-Ahmadie;Cancer Discov,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy;International Journal of Biological Macromolecules;2024-04

2. ATM–ESCO2–SMC3 axis promotes 53BP1 recruitment in response to DNA damage and safeguards genome integrity by stabilizing cohesin complex;Nucleic Acids Research;2023-06-28

3. Ubiquitination of Ku70 by Parkin promotes apoptosis of lens epithelial cells;The FEBS Journal;2023-04-10

4. Cantharidin Inhibits Proliferation of Liver Cancer by Inducing DNA Damage via KDM4A-Dependent Histone H3K36 Demethylation;Evidence-Based Complementary and Alternative Medicine;2022-07-11

5. Updates on Receptors Targeted by Heterocyclic Scaffolds: New Horizon in Anticancer Drug Development;Anti-Cancer Agents in Medicinal Chemistry;2021-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3